Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Alzheimer neurodegeneration, autophagy, and Abeta secretion: The ins and outs (comment on DOI 10.1002/bies.201400002)
Alzheimer's Disease And Nursing Homes
Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age
Alzheimer's Disease: Neuroprogesterone, Epoxycholesterol, and ABC Transporters as Determinants of Neurodesmosterol Tissue Levels and its Role in Amyloid Protein Processing
Alzheimer's disease under strain
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults
Alzheimer Disease Pathology in Subjects Without Dementia in 2 Studies of Aging: The Nun Study and the Adult Changes in Thought Study
Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia
Alzheimer's disease: rapid and slow progression
Alzheimer's Ahead
Alzheimer%26apos;s Disease: Presenilin 2-Sparing gamma-Secretase Inhibition Is a Tolerable A beta Peptide-Lowering Strategy
Alzheimer's disease and glaucoma
Alzheimer's Disease: Implications of the Updated Diagnostic and Research Criteria
Alzheimer Disease: Advances in Pathogenesis, Diagnosis, and Therapy
Alzheimer's disease is characterized by more low-density erythrocytes with increased volume and enhanced beta-amyloid x-40 content
Alzheimer's Disease-Associated Ubiquilin-1 Regulates Presenilin-1 Accumulation and Aggresome Formation
Alzheimer's Disease neurons fail the Acid Test
Alzheimer's disease-The Inexorable Epidemic
Alzheimer Pathology and Angiotension Receptor Blockers
Alzheimer's Disease: Past, Present, and Future
Alzheimer Disease and Its Growing Epidemic Risk Factors, Biomarkers, and the Urgent Need for Therapeutics
Alzheimer%26apos;s therapy targeting the beta-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
Alzheimer's Disease and the Fornix
Alzheimer%26apos;s disease: experimental models and reality
Alzheimer%26apos;s Biomarkers are Correlated with Brain Connectivity in order Adults Differentially during Resting and Task States
Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly
Alzheimer and his disease: a brief history
Alzheimer's disease qEEG Spectral analysis versus coherence. Which is the best measurement?
Alzheimer Disease Foreword
Alzheimer disease, memory and estrogen
Alzheimer's insight
Alzheimer disease and HIV A tangled story
Alzheimer%26apos;s Disease and Vascular Dementia: Neuropsychological Differentiation in Clinical Practice
Alzheimer%26apos;s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland
Alzheimer%26apos;s Disease Is Associated with a Low Prevalence of Hypertension
Alzheimer%26apos;s Disease and Semantic Deficits: A Feature-Listing Study
Alzheimer%26apos;s Disease: Critical Notes on the History of a Medical Concept
Alzheimer%26apos;s disease: a novel application for deep-brain stimulation?
Alzheimer%26apos;s disease lymphocytes: potential for biomarkers?
Alzheimer Mythology: A Time to Think Out of the Box
Alzheimer%26apos;s disease and modern lifestyle: what is the role of stress?
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome
Alzheimer%26apos;s and Parkinson%26apos;s diseases: The prion concept in relation to assembled A beta, tau, and alpha-synuclein
Alzheimer%26apos;s Disease: It%26apos;s More Than A beta
Alzheimer%26apos;s Disease Metaphors as Mirror and Lens to the Stigma of Dementia
Alzheimer%26apos;s Disease: A Heme-A beta Perspective
Alzheimer%26apos;s Disease: Individuals, Dyads, Communities, and Costs
Alzheimer%26apos;s Disease Genetics and ABCA7 Splicing
Alzheimer%26apos;s disease against peptides products of enzymatic cleavage APP protein: Biological, pathobiological and physico-chemical properties of fibrillating peptides
Alzheimer%26apos;s disease-associated mutations increase amyloid precursor protein resistance to gamma-secretase cleavage and the A beta 42/A beta 40 ratio
Alzheimer%26apos;s Disease: A Special Collection
Alzheimer's disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides - some aspects
Alzheimer's disease: An exacerbation of senile phenoptosis
Alzheimer's disease: Is this a brain specific diabetic condition?
Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy
Alzheimer's Disease in the Danish Malnutrition Period 1999-2007
Alzheimer's disease
Alzheimer's disease: as it was in the beginning
Alzheimer%26apos;s Disease: The Great Morbidity of the 21st Century Neuroangiogenesis (NAG) provides a vascular basis for understanding Alzheimer%26apos;s disease, senile dementias and cognitive decline with aging
Alzheimer%26apos;s disease and Down%26apos;s syndrome: Treating two paths to dementia
Alzheimer%26apos;s disease (AD) as a disorder of the plasma membrane
Alzheimer disease and pre-emptive suicide
Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome
Alzheimer's disease: How metal ions define beta-amyloid function
Alzheimer's Disease: From Firing Instability to Homeostasis Network Collapse
Alzheimer's disease disrupts alpha and beta-band resting-state oscillatory network connectivity
Alzheimer's Disease: A Systemic Review of Substantial Therapeutie Targets and the Leading Multi-functional Molecules
Alzheimer's Disease: A Journey (f)rom Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline
Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models
Alzheimer's Disease prevalence, costs, and prevention for military personnel and veterans
Alzheimer mouse brain tissue measured by time resolved fluorescence spectroscopy using single- and multi-photon excitation of label free native molecules
Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence
Alzheimer dementia: Starting, stopping drug therapy
Alzheimer病认知障碍和非认知功能改变的相关性
Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-labeling MRI and F-18-FDG PET
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A beta(1-42), total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Alzheimer disease biomarkers and synucleinopathy
AlzhaTV: A nonpharmacological intervention to manage behavioral and psychological symptoms in nursing home dementia patients
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline